Abstract
There is substantial evidence that there are dramatic sex-related differences in the incidence of cardiovascular disease, apparently related to the presence of steroid hormones. This is supported by the discovery of steroid hormone receptors in the heart and vasculature. More controversial is the area of sex-related differences in cardiac metabolism and function. A number of human and animal studies have demonstrated that estrogen and testosterone have cardiac metabolic effects. Additionally, research shows females have higher heart rates and various indices of function, including cardiac output and stroke volume, compared with males. However, some controversy exists, as other studies report that function in isolated muscle preparations is lower in females versus males. The reasons for these differences may reflect effects of sex hormones that are dependent on the conditions being studied. Cardiac function is reduced in postmenopausal females, suggesting that female sex hormones, specifically estrogen and progesterone, influence cardiac function. Apart from its well-documented vasodilatory effects, estrogen has also been shown to have negative inotropic effects and to reduce Ca2+ transients in cardiomyocytes. Similar results have been found for progesterone. Several studies show that testosterone administration appears to increase cardiac performance, while others show that it increases the stiffness of the ventricle due to increased collagen synthesis, thereby reducing diastolic performance. This review will discuss current evidence suggesting sex-related differences in cardiac metabolism and its energetics and function and will present the potential role of the principal sex steroid hormones.
Similar content being viewed by others
References
Arias-Loza PA, Hu K, Dienesch D, Mehlich AM, Konig S, Jazbutyte V, Neyses L, Hegele-Hartung C, Fritzemeier KH, Pelzer T (2007) Both estrogen receptor subtypes, α and β, attenuate cardiovascular remodeling in aldosterone salt-treated rats. Hypertens 50:432–438
Ben-Sira D, Sagiv M (1997) The effect of gender on left ventricular function immediately after the wingate test. Euro J Appl Physiol 75:549–553
Berger E, Borchard U, Hafner D, Pütz I, Weis TM (1997) Effects of 17β-estradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn-Schmiedeberg’s Arch Pharmacol 356:788–796
Beyer ME, Yu G, Hanke H, Hoffmeister HM (2001) Acute gender-specific hemodynamic and inotropic effects of 17β-estradiol on rats. Hypertens 38:1003–1010
Calovini T, Haase H, Morano I (1995) Steroid-hormone regulation of myosin subunit expression in smooth and cardiac muscle. J Cell Biochem 59:69–78
Campbell SE, Febbraio MA (2001) Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. Am J Physiol Endocrinol Metab 281:E803–E808
Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KDR, Schaefer E, Kajstura J, Anversa P, Sussman MA (2001) Myocardial Akt activation and gender. Increased nuclear activity in females versus males. Circ Res 88:1020–1027
Capasso JM, Remily RM, Smithe RH, Sonnenblick EH (1983) Sex differences in myocardial contractility in the rat. Basic Res Cardiol 78:156–171
Cavasin MA, Sakney SS, Yu AL, Menon S, Yang XP (2003) Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 284:H1560–H1569
Chu SH, Goldspink P, Kowalski J, Beck J, Schwertz DW (2006) Effect on estrogen on calcium-handling proteins, β-adrenergic receptors, and function in rat heart. Life Sci 79:1257–1267
Cittadini A, Strömer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS (1996) Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circ 93:800–809
Convertino VA (1998) Gender differences in autonomic functions associated with blood pressure regulation. Am J Physiol 275:R1909–R1920
Czubryt MP, Espira L, Lamoureux L, Abrenica B (2006) The role of sex in cardiac function and disease. Can J Physiol Pharmacol 84:93–109
Depre C, Hue L (1994) Cyclic GMP in the perfused rat heart. Effect of ischaemia, anoxia and nitric oxide synthase inhibitor. FEBS Lett 345:241–245
Dodds ML, Kargacin ME, Kargacin GJ (2001) Effects of anti-oestrogens and β-estradiol on calcium uptake by cardiac sarcoplasmic reticulum. Brit J Pharmacol 132:1374–1382
Du XJ, Riemersma RA, Dart AM (1995) Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function. Cardiovasc Res 30:161–165
Edén S (1979) Age- and sex-related differences in episodic growth hormone secretion in the rat. Endocrinol 105:555–560
Fuenmayor AJ, Ramirez L, Fuenmayor AM (2000) Left ventricular function and autonomic nervous system balance during two different stages of the menstrual cycle. Int J Cardiol 72:243–246
Greenspan FS, Gardner DG (2004) Greenspan’s basic & clinical endocrinology. Lange Medical Books/McGraw-Hill, New York, p 976
Haring R, John U, Volzke H, Nauck M, Dorr M, Felix SB, Wallaschofski H (2012) Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality. Gend Med 9(6):557–568
Hart MV, Hosenpud JD, Hohimer AR, Morton MJ (1985) Hemodynamics during pregnancy and sex steroid administration in guinea pigs. Am J Physiol 249:R179–R185
Haykowsky M, Chan S, Bhambhani Y, Syrotuik D, Quinney H, Bell G (1998) Effects of combined endurance and strength training on left ventricular morphology in male and female rowers. Can J Cardiol 14:387–391
Ho KKL, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22(suppl A):6A–13A
Hügel S, Neubauer S, Lie SN, Ernst R, Horn M, Schmidt HHHW, Allolio B, Reincke M (1999) Multiple mechanisms are involved in the acute vasodilatory effect of 17β-estradiol in the isolated perfused rat heart. J Cardiovasc Pharmacol 33:852–858
Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D (2002) Noncardiovascular disease outcomes during 6.8 years of hormone therapy. J Am Med Assoc 288:58–66
Ingegno MD, Money SR, Thelmo W, Greene GL, Davidian M, Jaffe BM, Pertschuk LP (1988) Progesterone receptors in the human heart and great vessels. Lab Investig 59:353–356
Johnson MR (1994) Heart failure in women: a special approach? J Heart Lung Transpl 13:S130–S134
Johnson BD, Zheng W, Korach KS, Scheuer T, Catterall WA, Rubanyi GM (1997) Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J Gen Physiol 110:135–140
Koenig H, Fan CC, Goldstone AD, Lu CY, Trout JJ (1989) Polyamines mediate androgenic stimulation of calcium fluxes and membrane transport in rat heart myocytes. Circ Res 64:415–426
Leblanc N, Chartier D, Gosselin H, Rouleau JL (1998) Age and gender differences in excitation-contraction coupling of the rat ventricle. J Physiol 511:553–548
LeGros T, McConnell D, Murry T, Edavettal M, Racey-Burns LA, Shepherd RE, Burns AH (2000) The effects of 17α-methyltestosterone on myocardial function in vitro. Med Sci in Sports Exercise 32:897–903
Lerner DJ, Kannel WB (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111:383–390
Lev EI, Pines A, Drory Y, Rotmensch HH, Tenenbaum A, Fisman EZ (1998) Exercise-induced aortic flow parameters in early postmenopausal women and middle-aged men. J Internal Med 243:275–280
Li HY, Bian JS, Kwan YW, Wong TM (2000) Enhanced responses to 17β-estradiol in rat hearts treated with isoproterenol: involvement of a cyclic AMP-dependent pathway. J Pharmacol Exp Ther 293:592–598
Light KC, Hinderliter AL, West SG, Grewen KM, Steege JF, Sherwood A, Girdler SS (2001) Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women. J Hypertens 19:269–278
Lin AL, Schultz JJ, Brenner RM, Shain SA (1990) Sexual dimorphism characterized baboon myocardial androgen receptors but not myocardial estrogen and progesterone receptors. J Steroid Biochem Mol Biol 37:85–95
Liu L, Fan QI, El-Zaru MR, Vanderpool K, Hines RN, Marsh JD (2000) Regulation of DHP receptor expression by elements in the 5′-flanking sequence. Am J Physiol 278:H1153–H1162
Lopaschuk GD, Kelly DP (2008) Signalling in cardiac metabolism. Cardiovasc Res 79:205–207
Luczak ED, Leinwand LA (2009) Sex-based cardiac physiology. Annu Rev Physiol 71:1–18
MacLellan WR, Schneider MD (1997) Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 81:137–144
Magness RR, Rosenfeld CR (1989) Local and systemic estradiol-17β: effects on uterine and systemic vasodilation. Am J Physiol 256:E536–E542
Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ (1998) Androgen receptors mediate hypertrophy in cardiac myocytes. Circ 98:256–261
Mendelsohn ME (2000) Mechanisms of estrogen action in the cardiovascular system. J Steroid Biochem Mol Biol 74:337–343
Mendoza J, De Mello WC (1974) Influence of progesterone on membrane potential and peak tension of myocardial fibres. Cardiovasc Res 8:352–361
Merz CNB, Moriel M, Rozanski A, Klein J, Berman DS (1996) Gender-related differences in exercise ventricular function among healthy subjects and patients. Am Heart J 131:704–709
Modena MG, Muia N Jr, Aveta P, Molinari R, Rossi R (1999) Effects of transdermal 17β-estradiol on left ventricular anatomy and performance in hypertensive women. Hypertens 34:1041–1046
Nillson SE, Fransson E, Brismar K (2009) Relationship between serum progesterone concentrations and cardiovascular disease, diabetes, and mortality in elderly Swedish men and women: an 8-year prospective study. Gend Med 6(3):433–443
Pasanen S, Ylikomi T, Syvälä H, Tuohimaa P (1997) Distribution of progesterone receptor in chicken: novel target organs for progesterone and estrogen action. Mol Cell Endocrinol 135:79–91
Patterson E, Ma L, Szabo B, Robinson CP, Thadani U (1998) Ovariectomy and estrogen-induced alterations in myocardial contractility in female rabbits: role of the L-type calcium channel. J Pharmacol Exp Ther 284:586–591
Pelzer T, Jazbutyte V, Hu K, Segrer S, Nahrendorf M, Nordbeck P, Bonz AW, Much J, Fritzemeier KH, Hegele-Hartung C, Ertl G, Neyses L (2005) The estrogen receptor-α agonist 16α-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res 1:604–612
Pelzer T, Schumann M, Neumann M, de Jager T, Stimpel M, Serfling E, Neyses L (2000) 17β-estradiol prevents programmed cell death in cardiac myocytes. Biochem Biophys Res Comm 268:192–200
Peterson LR, Soto PF, Herrero P, Schechtman KB, Dence C, Gropler RJ (2007) Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 14(4):573–581
Prelevic GM, Beljic T (1994) The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal women. Maturitas 20:37–44
Raddino R, Manca C, Poli E, Bolognesi R, Visioli O (1986) Effect of 17β-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn 281:57–65
Raddino R, Poli E, Pelà G, Manca C (1989) Action of steroid sex hormones on the isolated rabbit heart. Pharmacol 38:185–190
Re M, Gemelli A, Falcone M, Gulluni S, Ciriaco O, Sorcini G, Pepe M, D’Arezzo A, Canova R, Clemenzia G (1986) A study of cardiac function in relation to the menstrual cycle. Panminerva Medica 28:11–14
Ren J, Samson WK, Sowers JR (1999) Insulin-like growth factor 1 as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 31:2049–2061
Scheuer J, Malhotra A, Schaible TG, Capasso J (1987) Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 61:12–19
Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Porcellati C (1998) Early cardiac changes after menopause. Hypertens 32:764–769
Sites CK, Tischler MD, Blackman JA, Niggel J, Fairbank JT, O'Connell M, Ashikaga T (1999) Effect of short-term hormone replacement therapy on left ventricular mass and contractile function. Fertil Steril 71:137–143
Sitzler G, Lenz O, Kitler H, La Rosee K, Böhm M (1996) Investigation of the negative inotropic effects of 17β-oestradiol in human isolated myocardial tissues. Br J Pharmacol 119:43–48
Snabes MC, Payne JP, Kopelen HA, Dunn JK, Young RL, Zoghbi WA (1997) Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo-controlled, crossover trial. Obstet Gynecol 89:332–339
Stanley WC, Recchia RA, Lopaschuk GD (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85:1093–1129
Tannenbaum GS, Martin JB (1976) Evidence for an endogenous utradian rhythm governing growth hormone secretion in the rat. Endocrinol 98:562–570
Taylor AH, Al-Azzawi F (2000) Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol 24:145–155
The Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Am Med Assoc 273:199–208
Vanhaesebroeck B, Alessi DR (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346:561–576
Villari B, Campbell SE, Schneider J, Vassalli G, Chiarello M, Hess OM (1995) Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J 16:1410–1419
Voutilainen S, Hippeläinen M, Hulkko S, Karppinen K, Ventilä M, Kupari M (1993) Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women. Am J Cardiol 71:614–617
Wallen WJ, Cserti C, Belanger MP, Wittnich C (2000) Gender-differences in myocardial adaptation to afterload in normotensive and hypertensive rats. Hypertens 36:774–779
Wang SN, Wyeth RP, Kennedy RH (1998) Effects of gender on the sensitivity of rat cardiac muscle to extracellular Ca2+. Eur J Pharmacol 361:73–77
Younis LT, Melin JA, Robert AR, Detry JMR (1990) Influence of age and sex on left ventricular volumes and ejection fraction during upright exercise in normal subjects. Eur Heart J 11:916–924
Zabalgoitia M, Rahman NU, Haley WE, Oneschuk L, Yarows S, Yunis C, Lucas C, Linn W, Krause L, Amerena J (1996) Gender dimorphism in cardiac adaptation to hypertension is unveiled by prior treatment and efficacy. Am J Cardiol 78:838–840
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published as part of the special issue on sex differences in health and disease: brain and heart connections.
Rights and permissions
About this article
Cite this article
Wittnich, C., Tan, L., Wallen, J. et al. Sex differences in myocardial metabolism and cardiac function: an emerging concept. Pflugers Arch - Eur J Physiol 465, 719–729 (2013). https://doi.org/10.1007/s00424-013-1232-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-013-1232-1